newsfilter
← Latest News
PR Newswire·

ESSA Pharma Inc. Amends Agreement with XenoTherapeutics

ESSA Pharma Inc. ("ESSA," or the "Company") (NASDAQ: EPIX) today announced that it has reached an agreement to amend its previously announced...